Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

CPI CARD GROUP INC. (PMTS)

  • Business News
  • May 05, 2026, 11:00 UTC
  • 3
  • 1 comments

CPI Reports Solid First Quarter Results

Market reaction Comment Full text

ADAPTHEALTH CORP. (AHCO)

  • Business News
  • May 05, 2026, 11:00 UTC
  • 3
  • 1 comments

AdaptHealth Corp. Announces First Quarter 2026 Results

Market reaction Comment Full text

SELECTQUOTE, INC. (SLQT)

  • Business News
  • May 05, 2026, 11:00 UTC
  • 5
  • 1 comments

SelectQuote, Inc. Reports Third Quarter of Fiscal Year 2026 Results

Market reaction Comment Full text

DIGITALOCEAN HOLDINGS, INC. (DOCN)

  • Business News
  • May 05, 2026, 11:00 UTC
  • 4
  • 1 comments

DigitalOcean Announces First Quarter 2026 Financial Results

Market reaction Comment Full text

KNIFE RIVER CORP (KNF)

  • Business News
  • May 05, 2026, 11:00 UTC
  • 2
  • 1 comments

Knife River Corporation Reports First Quarter 2026 Financial Results

Market reaction Comment Full text

D-WAVE QUANTUM INC. COMMON SHARES (QBTS)

  • Business News
  • May 05, 2026, 11:00 UTC
  • 3
  • 1 comments

D-Wave Announces Qubits Europe 2026 Quantum Computing User Conference

Market reaction Comment Full text

ORTHOFIX MEDICAL INC. (OFIX)

  • Business News
  • May 05, 2026, 11:00 UTC
  • 3
  • 1 comments

Orthofix Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine Commercial Channel Actions; Reaffirms Full-Year 2026 Financial Guidance

Market reaction Comment Full text

REPOSITRAK, INC. (TRAK)

  • Business News
  • May 05, 2026, 11:00 UTC
  • 2
  • 1 comments

World Food Products Expands Use of ReposiTrak to Strengthen End-to-End Supply Chain Compliance

Market reaction Comment Full text

RELMADA THERAPEUTICS, INC. (RLMD)

  • Business News
  • May 05, 2026, 11:00 UTC
  • 2
  • 1 comments

Relmada Therapeutics to Present NDV-01 Abstracts at AUA2026

Market reaction Comment Full text

VIRIDIAN THERAPEUTICS, INC.\DE (VRDN)

  • Business News
  • May 05, 2026, 11:00 UTC
  • 3
  • 1 comments

Viridian Therapeutics Announces Positive Topline Results from Elegrobart Phase 3 REVEAL‑2 Clinical Trial in Chronic Thyroid Eye Disease

Market reaction Comment Full text
  • Previous
  • 363
  • 364
  • 365
  • 366
  • 367
  • Next

Search

News categories

  • Technical Exchange News(12380)
  • Event(6229)
  • SEC News(274042)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158497)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin